anti-hiv-agents

Documents about anti-hiv-agents

• HIV drug resistance: tackling HIV drug resistance: trends, guidelines and global actions: policy brief#466860WHO IRIS
• Report on the global action plan on HIV drug resistance 2017–2021#466859WHO IRIS
• Integrating HIV prevention into practice#221522UNSWorks Repository
• Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030#151807WHO IRIS
• HIV and Ovarian Reserve#848334ClinicalTrials.gov
• The Mochudi Prevention Project ART Protocol#886999ClinicalTrials.gov
• Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients#811365ClinicalTrials.gov
• Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients#813103ClinicalTrials.gov
• The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs#810911ClinicalTrials.gov
• Outcomes of Anti-HIV Therapy During Early HIV Infection#826463ClinicalTrials.gov
• A Study to Compare Two Anti-HIV Drug Combinations#915018ClinicalTrials.gov
• Safety and Effectiveness of a Combination Anti-HIV Drug Treatment#847826ClinicalTrials.gov
• Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring#837042ClinicalTrials.gov
• A Study to Compare Two Different Anti-HIV Drug Regimens#854656ClinicalTrials.gov
• T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs#894010ClinicalTrials.gov
• A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations#1009201ClinicalTrials.gov
• Viracept Expanded Access Program#804039ClinicalTrials.gov
• Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations#836125ClinicalTrials.gov
• The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients#903227ClinicalTrials.gov
• Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women#827312ClinicalTrials.gov
• The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients#898316ClinicalTrials.gov
• Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs#901545ClinicalTrials.gov
• A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa#812200ClinicalTrials.gov
• The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#863314ClinicalTrials.gov
• A Study of 1592U89 in HIV-Infected Children#865498ClinicalTrials.gov
• Body Compartment Pharmacokinetics of Anti- Retroviral Agents That May be Used for Future HIV Post- Exposure Prophylaxis.#892074ClinicalTrials.gov
• A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients#900756ClinicalTrials.gov
• A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs#906316ClinicalTrials.gov
• Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients#870265ClinicalTrials.gov
• A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure#807558ClinicalTrials.gov
• A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments#844465ClinicalTrials.gov
• Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients#1007518ClinicalTrials.gov
• Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients#801925ClinicalTrials.gov
• A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients#876914ClinicalTrials.gov
• A Study of LXR015-1 in HIV-Infected Patients#810596ClinicalTrials.gov
• Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs#969920ClinicalTrials.gov
• Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#803745ClinicalTrials.gov
• T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs#805763ClinicalTrials.gov
• Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)#872610ClinicalTrials.gov
• Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir#915121ClinicalTrials.gov
• The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients#804761ClinicalTrials.gov
• Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth#899815ClinicalTrials.gov
• The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients#881286ClinicalTrials.gov
• The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs#838354ClinicalTrials.gov
• A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#898005ClinicalTrials.gov
• A Comparison of 141W94 and Indinavir in HIV-Infected Patients#805998ClinicalTrials.gov
• Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs#828540ClinicalTrials.gov
• A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs#882619ClinicalTrials.gov
• The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children#910258ClinicalTrials.gov
• Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis#888605ClinicalTrials.gov